Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
13.11B | 21.01B | 24.42B | 43.64B | 38.58B | Gross Profit |
-7.23B | 161.62M | 3.36B | 12.05B | 11.10B | EBIT |
-8.02B | -914.93M | -7.96B | 9.90B | 9.70B | EBITDA |
-9.88B | -2.47B | -7.62B | 10.12B | 10.51B | Net Income Common Stockholders |
-16.61B | -4.51B | -9.62B | 4.75B | 4.94B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
840.48M | 1.73B | 2.74B | 14.72B | 33.53B | Total Assets |
88.54B | 121.11B | 149.93B | 198.39B | 191.50B | Total Debt |
51.66B | 49.96B | 50.28B | 56.63B | 64.80B | Net Debt |
50.82B | 48.23B | 47.54B | 41.92B | 31.26B | Total Liabilities |
96.41B | 110.45B | 130.02B | 155.74B | 155.62B | Stockholders Equity |
-16.42B | 633.38M | 5.75B | 19.26B | 18.78B |
Cash Flow | Free Cash Flow | |||
0.00 | 4.22B | -546.33M | 78.90M | 1.14B | Operating Cash Flow |
0.00 | 4.25B | -510.64M | 128.97M | 1.31B | Investing Cash Flow |
0.00 | 56.45M | 1.57B | -22.32B | -7.75B | Financing Cash Flow |
0.00 | -5.31B | -13.05B | 3.41B | 14.30B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
$49.81M | ― | -3320.67% | ― | ― | ― | ||
61 Neutral | $2.83B | 10.92 | 0.41% | 8438.90% | 5.75% | -21.03% | |
€37.88M | ― | -280.53% | ― | ― | ― | ||
€40.24M | ― | -42.12% | ― | ― | ― | ||
€45.17M | ― | ― | ― | ― | |||
20 Underperform | HK$379.06M | ― | ― | -55.88% | -10.72% | ||
20 Underperform | HK$358.57M | ― | -465.56% | ― | -33.54% | -100.40% |